High Pointe Capital Management’s Medtronic MDT Stock Holding History

High Pointe Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,380	Closed	-$395K	–	87
2020 Q1	$395K	Sell	4,380 -90	-2%	-$9.57K	0.56%	53
2019 Q4	$507K	Sell	4,470 -5,500	-55%	-$604K	0.6%	57
2019 Q3	$1.08M	Buy	9,970 +400	+4%	+$41.7K	1.48%	25
2019 Q2	$932K	Hold	9,570	–	–	1.31%	30
2019 Q1	$872K	Sell	9,570 -8,330	-47%	-$746K	1.19%	33
2018 Q4	$1.63M	Buy	17,900 +30	+0.2%	+$2.8K	2.68%	6
2018 Q3	$1.76M	Hold	17,870	–	–	2.37%	10
2018 Q2	$1.53M	Hold	17,870	–	–	2.18%	11
2018 Q1	$1.43M	Buy	17,870 +1,995	+13%	+$165K	1.97%	13
2017 Q4	$1.28M	Buy	15,875 +205	+1%	+$16.4K	1.75%	21
2017 Q3	$1.22M	Sell	15,670 -280	-2%	-$23.2K	1.78%	21
2017 Q2	$1.42M	Buy	15,950 +5,350	+50%	+$451K	2.2%	11
2017 Q1	$854K	Buy	+10,600	New	+$828K	1.35%	29
2015 Q4	–	Sell	-12,940	Closed	-$866K	–	177
2015 Q3	$866K	Sell	12,940 -530	-4%	-$39K	0.41%	86
2015 Q2	$998K	Sell	13,470 -260	-2%	-$19.9K	0.36%	121
2015 Q1	$1.07M	Sell	13,730 -3,340	-20%	-$253K	0.38%	108
2014 Q4	$1.23M	Buy	17,070 +4,070	+31%	+$283K	0.54%	86
2014 Q3	$805K	Buy	13,000 +7,450	+134%	+$474K	0.35%	116
2014 Q2	$354K	Hold	5,550	–	–	0.13%	137
2014 Q1	$342K	Hold	5,550	–	–	0.13%	134
2013 Q4	$319K	Sell	5,550 -500	-8%	-$28.4K	0.13%	143
2013 Q3	$322K	Buy	6,050 +1,650	+38%	+$88.8K	0.13%	127
2013 Q2	$226K	Buy	+4,400	New	+$217K	0.1%	133

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

High Pointe Capital Management's MDT Position: Q2 2020 in Review

High Pointe Capital Management sold out of Medtronic (MDT) in Q2 2020, closing a stake of 4,380 shares — an estimated $395K sold.

High Pointe Capital Management first reported a position in MDT in Q2 2013 and held it in 23 quarters. The position peaked at $1.76M in Q3 2018. 1,759 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

High Pointe Capital Management reported no remaining Medtronic position as of Q2 2020 after selling out during the quarter.
High Pointe Capital Management sold 4,380 Medtronic shares in Q2 2020, an estimated $395K.
High Pointe Capital Management first reported a position in Medtronic in Q2 2013 and held it in 23 quarters.
High Pointe Capital Management's Medtronic position peaked at $1.76M in Q3 2018.
1,759 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on High Pointe Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.